FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110975084> ?p ?o ?g. }

• W2110975084 endingPage "S63" @default.
• W2110975084 startingPage "S55" @default.
• W2110975084 abstract "The effects of fluvastatin and bezafibrate on lipids, lipoproteins, and apoproteins (apo) were investigated in a multicenter randomized, double-blind, parallel-group study. After 8 weeks of strictly controlled (computer-based assessment) dietary stabilization, patients with primary hypercholesterolemia (low-density lipoprotein cholesterol [LDL-C] ≥160 mg/dL; triglycerides ⪯300 mg/dL) were enrolled into a 6-week placebo phase. Altogether, 131 patients were randomized to receive either fluvastatin at 40 mg once daily (n = 64; mean age 53 years) or bezafibrate at 400 mg once daily (n = 67; mean age 52 years) for 12 weeks. Compliance with the diet was monitored (3-day food records) after 6 and 12 weeks. Fluvastatin led to significant reductions in LDL-C (−23%), total cholesterol (−17%), LDL-C/high-density lipoprotein cholesterol (HDL-C) (−24%) and apo B (−19%). Fluvastatin significantly increased LpA-I (+8%) and apo E (+20%). Bezafibrate produced significant reductions in LDL-C (−17%), total cholesterol (−13%), LDL-C/HDL-C (−24%), triglycerides (−28%), apo B (−15%), and LpA-I (−10%) and significantly increased HDL-C (+12%), apo A-I (+9%), apo A-II (+30%), apo E (+14%), and Lp(a) (+3%). No clinically notable increases in levels of liver enzymes or creatine phosphokinase were observed with either treatment. Both treatments were well tolerated. There was a low incidence of adverse events that tended to be mild and included headache, muscular pain, angina, and dyspepsia. The frequency of adverse events was similar in both treatment groups, and no significant differences in dietary behavior were observed. In conclusion, fluvastatin is a well tolerated 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor for the treatment of primary hypercholesterolemia. Effects of fluvastatin on LpA-I occur irrespective of changes in HDL-C." @default.
• W2110975084 created "2016-06-24" @default.
• W2110975084 creator A5002434059 @default.
• W2110975084 creator A5013547361 @default.
• W2110975084 creator A5040079457 @default.
• W2110975084 creator A5043781155 @default.
• W2110975084 creator A5048396622 @default.
• W2110975084 creator A5067294256 @default.
• W2110975084 creator A5069028201 @default.
• W2110975084 creator A5070842959 @default.
• W2110975084 creator A5073431279 @default.
• W2110975084 creator A5083073503 @default.
• W2110975084 creator A5083297968 @default.
• W2110975084 creator A5088799320 @default.
• W2110975084 date "1994-06-01" @default.
• W2110975084 modified "2023-10-15" @default.
• W2110975084 title "Treatment of primary hypercholesterolemia: Fluvastatin versus bezafibrate" @default.
• W2110975084 cites W1848464647 @default.
• W2110975084 cites W1870892720 @default.
• W2110975084 cites W1878775584 @default.
• W2110975084 cites W1909180518 @default.
• W2110975084 cites W1973421436 @default.
• W2110975084 cites W1973739555 @default.
• W2110975084 cites W1994536728 @default.
• W2110975084 cites W2000519468 @default.
• W2110975084 cites W2000534441 @default.
• W2110975084 cites W2006705370 @default.
• W2110975084 cites W2007542782 @default.
• W2110975084 cites W2009973903 @default.
• W2110975084 cites W2012789522 @default.
• W2110975084 cites W2041575512 @default.
• W2110975084 cites W2042385191 @default.
• W2110975084 cites W2048569097 @default.
• W2110975084 cites W2053090563 @default.
• W2110975084 cites W2057065030 @default.
• W2110975084 cites W2057612989 @default.
• W2110975084 cites W2059931409 @default.
• W2110975084 cites W2065510904 @default.
• W2110975084 cites W2076357141 @default.
• W2110975084 cites W2076809869 @default.
• W2110975084 cites W2081471622 @default.
• W2110975084 cites W2089632613 @default.
• W2110975084 cites W2092101873 @default.
• W2110975084 cites W2112698709 @default.
• W2110975084 cites W2115572248 @default.
• W2110975084 cites W2116404316 @default.
• W2110975084 cites W2117882803 @default.
• W2110975084 cites W2132942256 @default.
• W2110975084 cites W2139149310 @default.
• W2110975084 cites W2143465004 @default.
• W2110975084 cites W2146966629 @default.
• W2110975084 cites W2154749127 @default.
• W2110975084 cites W2155602575 @default.
• W2110975084 cites W2324712847 @default.
• W2110975084 cites W2341665659 @default.
• W2110975084 cites W2341922045 @default.
• W2110975084 cites W2950135326 @default.
• W2110975084 cites W4236225985 @default.
• W2110975084 cites W4242564969 @default.
• W2110975084 cites W4248021162 @default.
• W2110975084 cites W4254363271 @default.
• W2110975084 doi "https://doi.org/10.1016/0002-9343(94)90233-x" @default.
• W2110975084 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8017468" @default.
• W2110975084 hasPublicationYear "1994" @default.
• W2110975084 type Work @default.
• W2110975084 sameAs 2110975084 @default.
• W2110975084 citedByCount "19" @default.
• W2110975084 countsByYear W21109750842012 @default.
• W2110975084 countsByYear W21109750842017 @default.
• W2110975084 countsByYear W21109750842018 @default.
• W2110975084 countsByYear W21109750842021 @default.
• W2110975084 countsByYear W21109750842022 @default.
• W2110975084 crossrefType "journal-article" @default.
• W2110975084 hasAuthorship W2110975084A5002434059 @default.
• W2110975084 hasAuthorship W2110975084A5013547361 @default.
• W2110975084 hasAuthorship W2110975084A5040079457 @default.
• W2110975084 hasAuthorship W2110975084A5043781155 @default.
• W2110975084 hasAuthorship W2110975084A5048396622 @default.
• W2110975084 hasAuthorship W2110975084A5067294256 @default.
• W2110975084 hasAuthorship W2110975084A5069028201 @default.
• W2110975084 hasAuthorship W2110975084A5070842959 @default.
• W2110975084 hasAuthorship W2110975084A5073431279 @default.
• W2110975084 hasAuthorship W2110975084A5083073503 @default.
• W2110975084 hasAuthorship W2110975084A5083297968 @default.
• W2110975084 hasAuthorship W2110975084A5088799320 @default.
• W2110975084 hasConcept C126322002 @default.
• W2110975084 hasConcept C134018914 @default.
• W2110975084 hasConcept C142724271 @default.
• W2110975084 hasConcept C197934379 @default.
• W2110975084 hasConcept C204787440 @default.
• W2110975084 hasConcept C27081682 @default.
• W2110975084 hasConcept C2776329913 @default.
• W2110975084 hasConcept C2776362216 @default.
• W2110975084 hasConcept C2778163477 @default.
• W2110975084 hasConcept C2778417548 @default.
• W2110975084 hasConcept C36880943 @default.
• W2110975084 hasConcept C62746215 @default.
• W2110975084 hasConcept C71924100 @default.

• next